SARS Envelope Antibody
| Code | Size | Price |
|---|
| PSI-3533-0.02mg | 0.02mg | £150.00 |
Quantity:
| PSI-3533-0.1mg | 0.1mg | £449.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Application: Enzyme-Linked Immunosorbent Assay (ELISA)
Documents
Further Information
Additional Names:
SARS-CoV Envelope Antibody: sM, 4, Envelope small membrane protein, E protein
Application Note:
SARS-CoV Envelope antibody can be used for the detection of SARS-CoV Envelope protein in ELISA. It will detect 5 ng of free peptide at 1 μg/mL.
Background:
SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.
Envelope protein is a small polypeptide that contains at least one ?-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication.
Background References:
- Marra et al. Science 2003;300:1399-404.
- Rota et al. Science 2003;300:1394-9.
- Navas-Nartin et al. J Neurovirol. 2004;10:75-85.
- Pervushin et al. PLoS Pathog. 2009; 5(7): e1000511.
Buffer:
SARS-CoV Envelope Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Homology:
Predicted reactivity based on immunogen sequence: SARS-CoV-2 Envelope protein: (identity 82%, homology 91%)
Immunogen:
Anti-SARS-CoV Envelope antibody (3533) was raised against a peptide corresponding to 11 amino acids near the carboxy terminus of SARS-CoV Envelope protein.
The immunogen is located within the last 50 amino acids of SARS-CoV Envelope.
The immunogen is located within the last 50 amino acids of SARS-CoV Envelope.
ISOFORMS:
SARS-CoV Envelope has one isoform (75aa).
NCBI Gene ID #:
1489671
NCBI Official Name:
Envelope small membrane protein
NCBI Official Symbol:
E
NCBI Organism:
SARS coronavirus
Physical State:
Liquid
Protein Accession #:
P59637
Protein GI Number:
30173401
Purification:
SARS-CoV Envelope Antibody is affinity chromatography purified via peptide column.
Research Area:
Neuroscience,Infectious Disease,COVID-19
Swissprot #:
P59637
User NOte:
Optimal dilutions for each application to be determined by the researcher.
References
- Siu, et al. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J Virol. 2008 Nov;82(22):11318-30. doi: 10.1128/JVI.01052-08. Epub 2008 Aug 27.PMID: 18753196
Related Products
| Product Name | Product Code | Supplier | SARS Envelope Peptide | PSI-3533P | ProSci | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|